Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea

Patients with classical Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocythemia (ET), and primary and secondary myelofibrosis (MF), are known to have an increased risk of second malignancies (SMs). Hydroxyurea (HU) is a guidel...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Rong, Shallis, Rory M., Stempel, Jessica M., Huntington, Scott F., Zeidan, Amer M., Gore, Steven D., Ma, Xiaomei, Podoltsev, Nikolai A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Health Services and Outcomes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989521/
https://www.ncbi.nlm.nih.gov/pubmed/35917456
http://dx.doi.org/10.1182/bloodadvances.2022008259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989521/
https://www.ncbi.nlm.nih.gov/pubmed/35917456
http://dx.doi.org/10.1182/bloodadvances.2022008259

Ejemplares similares